Sanofi (SNYNF) cash flow statement

SNYNFOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as SNY

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Feb 17, 2026Score 6/30

$78.48−0.07 (-0.09%)

Close on Oct 19, 2026Market cap $191.40BP/E 22.1Yield –

Sanofi cash flow statement

AnnualQuarterlyTTM

EUR USD

Millions of EUR, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31
Stock-Based Compensation	313	278	260	234	244	274	252	284	263	241	193
Deferred Income Taxes	-2,439	-802	-1,233	-529	-356	-221	-1,772	-727	-909	-542	-1,253
Change in Accounts Receivable	-1,202	-28	-472	-500	185	-134	-462	-35	-529	168	-493
Change in Inventory	-39	-477	-866	-918	-357	-593	-547	-701	-144	-326	-466
Change in Accounts Payable	398	789	258	340	451	86	169	270	577	447	241
Operating Cash Flow	10,750	9,081	10,258	10,526	10,522	7,418	7,715	5,547	7,379	7,838	8,290
Acquisitions	-9,394	-1,901	-2,535	-987	-5,594	-5,336	-488	–	–	–	–
Investing Cash Flow	-2,447	-4,407	-6,200	-2,075	-7,298	3,619	-1,183	-12,866	-2,896	-2,511	-3,011
Share Repurchases	-5,030	-302	-593	-497	-382	-822	-9.00	-1,101	-2,162	-2,908	-1,784
Stock Issued	177	187	195	188	186	203	162	177	319	305	573
Debt Issued	5,559	0	48	1,549	0	2,019	1,997	9,677	41	–	–
Debt Repaid	-2,622	-672	-3,684	-2,718	-2,241	-3,952	-2,067	787	2,368	–	–
Financing Cash Flow	-8,207	-5,763	-8,052	-5,821	-7,056	-6,485	-4,193	3,934	-7,902	-4,101	-3,578
Foreign Exchange Rate Adjustments	-47	-13	-32	8.00	15	-64	9.00	1.00	-74	-101	-232
Net Change in Cash	216	-1,269	-4,026	2,638	-3,817	4,488	2,502	-3,390	42	1,125	1,807
Income Taxes Paid	2,885	3,291	2,623	2,452	1,280	2,051	1,695	2,058	1,734	-2,096	-1,706

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY

Gross margin: –
Operating margin: –
Net margin: –
Return on equity, FY2025: 10.5%

Financial strength

Current ratio: 0.99
Debt to equity: 0.31
Debt to assets: 16.8%
Cash to current liabilities: 19.9%

Valuation

P/E ratio: 22.1
Price to sales: –
Price to book: 2.48
Dividend yield: –

See a number that looks wrong?